:Home :About Us :Apsos! Apsos! :Breeding Apsos :Champions :Galleries :Lineage :What's New Blog :Put the Pen to the Paper :Contact

:Anatomy :Color :Genetics :Renal Dysplasia :Reproduction :Standards
|
We strive to endow every puppy
As Dr. Battaglia so eloquently wrote in A New Kind of Breeder, "In the end, the future will be in the hands of those who take the time to develop their skills, use the new tools and apply the resources available. They will become part of the movement that practices thinking smarter, not working harder. They are the new kind of breeders and they have arrived." The Apso of the future based on the Apso of the past is definitely a theme throughout the FFT breeding program. For years, we utilized the traditional practice of line breeding. In recent years, the principles of population genetics have been incorporated, in particular because of the importance of producing healthy Apsos . For over ten years, we have been actively involved in DNA research, wanting to be part of the solution regarding genetic diseases. Our dogs have contributed DNA to a number of research projects. The main focus has been on Renal Dysplasia, wanting answers on a molecular level, with the eventual realization of another tool to help when planning our breeding program. Our compiled data, the foundation of the research leading to direct DNA tests for RD, is further explained in This Miserable Thing. And, published in the AKC Gazette, Debby helps educate breeders on how to use this new technology in A Pathway? Or a Superhighway? With this new technology, our breeding dogs can be DNA tested rather than screened with kidney biopsies. We monitor other breed problems with the intention of addressing an issue - should it arise - before it can become prevalent in our lineage. Above all, do no harm.
|
Genetic tests provide breeders with knowledge that can be very useful if used correctly. Leslie Baumann succinctly describes an "Above all, do no harm" approach for using the RD test:
In my opinion, when we had
more clears in the breeding population, the breed actually had a greater
chance of bottlenecking on those dogs. If we all started out with plenty of
clears, our human tendency would be to ditch the carriers, removing all sorts
of worthwhile strains from the breed, and only breed the clears. Having a high
rate of carriers makes a breeder's job harder but I would argue that the fact
that more of us are forced to continue to breed our healthy carriers may end
up protecting genetic diversity rather than limiting it. At best, we can
remove the mutation from the breed. At worst, we may find we have to live with
it in a certain percentage of the breed population. But at least we'll know
which dogs are which!!!! As Kathy R. points out, we may be in something of the
same boat as folks with breeds that carry for the merle gene or the hairless
gene...they have to "zig/zag" to get the color/hair type they want without
producing the defects that those genes, in their homozygous form, can produce.
For the next two or three generations, we may have to do a similar "zig zag"
to get what we want. But just because it's hard, seems to me is no reason to
give up!!!!
From Dr. Catherine Marley: Good news from Dr. Whiteley! She has results coming out now on the test for the "C" mutation. The previously seen sequence mutations "A" and "B" that affected the same gene seem now to have represented alteration in the nucleotides of the gene, peculiar to Lhasas and Shih-Tzus, that may only represent a "weak spot" in the DNA which is susceptible to mutation. The real culprit seems to be "C", also a mutated sequence in the same gene. Mary has found a 100% correspondence between the disease and the presence of “C”. She has also found that “C” prevents the formation of any protein by the gene. All active genes are templates for proteins. These proteins are the enzymes and messengers that control development and all chemical functions of the body. Whatever the critical protein is, that controls some aspect of development of the renal system, IT IS NOT MADE by the chromosome with the “C” mutation. The implication of this is that if there are two “C” mutations the protein is completely missing. And if the animal has only one “C”, the animal may have some deficiency or delay in the manufacture of the essential protein which governs development of the kidney. The former would totally prevent differentiation of the renal system, while the latter would present itself as a variable degree of incomplete development of the kidney - which is exactly what we see in HKD/JRD. The further implications of this fit very well with what Mary has discovered. NONE of her DNA specimens so far, taken from living animals, have contained two copies of the "C" mutation. Since the heterozygous state (one mutation, one normal) is fairly common, it is statistically possible to have NO homozygotes ONLY if all the homozygotes fail to develop in utero. If the protein in question is one that induces the embryonic mesenchyme to develop a kidney, and possibly other mesenchymal structures, then the embryo which lacks that very early induction protein most likely will not develop past an early stage.
Normally,
breeding of two carriers (heterozygotes) produces 25% clears, 50 %
heterozygotes, and 25% homozygotes. Our previous understanding of the breeding
statistics was that 75% of the offspring of two
carriers were at risk of
having and transmitting HKD/JRD. The "C" mutation improves the odds that an
individual in one of our litters is a "clear" since homozygotes are all lost
at conception or shortly thereafter. What we will actually see in our litters
from two heterozygous animals, is 33% clears, and 67% heterozygotes. Of
course, because some embryos are lost, litters might be smaller.
|
:Home :About Us :Apsos! Apsos! :Breeding Apsos :Champions :Galleries :Lineage :What's New Blog :Put the Pen to the Paper :Contact